New research explores how data can help detect disease earlier and improve patient care

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions Saved Articles My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire New research explores how data can help detect disease earlier and improve patient careAuthor of the article: You can save this article by registering for free here. Or sign-in if you have an account.VANCOUVER, British Columbia, Aug. 10, 2026 (GLOBE NEWSWIRE) — Every patient has a story, yet no single source of health information tells the whole story. What if researchers could use data to identify multiple sclerosis years before symptoms become apparent? Predict inflammatory bowel disease flare-ups before they occur? Or understand why two patients with similar heart disease have very different outcomes?THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountGenome BC is supporting six new research projects designed to answer these questions. Funded through Genome BC’s Data Access, Integration and Analysis 2 (DAIA2) program, the projects will use the province’s Health Data Platform BC to securely integrate genomic information, healthcare records and other sources of health information.By creating a more complete picture of disease, researchers hope to uncover new evidence that could lead to earlier diagnosis, more personalized care and better health outcomes for British Columbians.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try again“For years, our healthcare system has generated vast amounts of health information, but much of it remained siloed and disconnected. Now that is changing and we are increasingly able to responsibly bring that information together to answer questions that matter to patients,” said Dr. Zsuzsanna Hollander, Interim Vice President, Research and Innovation, Genome BC.Recognizing multiple sclerosis earlier. Researchers will investigate whether combining inherited genetic risk with patterns of healthcare use could reveal early warning signs of multiple sclerosis years before diagnosis, enabling earlier recognition and treatment.Improving care for heart disease. Cardiovascular and metabolic diseases are the leading causes of illness and death in British Columbia. This project will evaluate whether genomic information can strengthen prediction and management of these types of diseases by combining whole genome sequencing with heart imaging, laboratory data and long-term health outcomes.Predicting inflammatory bowel disease flare-ups. Researchers will study how diet, the gut microbiome and genomic information interact to improve prediction of flare-ups and support more personalized care for people living with inflammatory bowel disease.Additional projects will investigate new biomarkers for chronic obstructive pulmonary disease (COPD), evaluate whether genetic risk scores can improve prediction of COPD outcomes and examine the long-term health impacts of prenatal exposure to wildfire smoke.DAIA2 supports research that combines genomic information with data held through Health Data Platform BC, helping researchers investigate complex health questions while maintaining strong safeguards for privacy and security. Together, the six projects will help build evidence for more precise, informed and responsive healthcare in British Columbia.About Genome British ColumbiaGenome BC is a not-for-profit organization that has advanced genomics research and innovation for more than 25 years, growing a world class life sciences sector in BC and delivering sustainable benefits for British Columbia, Canada and beyond. Genome BC has attracted over $1.2 billion in direct co-investment to the province, which has contributed to funding more than 650 genomics research and innovation projects. These initiatives enhance healthcare and address environmental and natural resource challenges, improving the lives of British Columbians. Genome BC also integrates genomics into society by supporting responsible research and innovation and fostering an understanding and appreciation of the life sciences among educators, students and the public. www.genomebc.caCONTACT: Brad Lyle, Communications Manager, Brand and MarketingGenome BC, 778-999-8195, blyle@genomebc.caThis advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.